XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 29, 2022
Oct. 30, 2021
Cash flows from operating activities:    
Net income $ 2,459,619 $ 2,342,611
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 656,081 647,610
Loss on early extinguishment of debt 0 242,248
Impairment on equity investment 217,619 0
Loss on property disposals and impairment charges 6,664 526
Deferred income tax provision (benefit) 34,655 (44,285)
Share-based compensation 94,564 156,575
Changes in assets and liabilities:    
(Increase) in accounts receivable (68,729) (155,554)
(Increase) in merchandise inventories (2,544,990) (2,287,326)
(Increase) in income taxes recoverable (27,644) (50,428)
(Increase) decrease in prepaid expenses and other current assets (72,128) 20,779
Increase in accounts payable 647,264 611,934
(Decrease) increase in accrued expenses and other liabilities (237,272) 557,065
(Decrease) increase in income taxes payable (103,229) 56,426
Increase (decrease) in net operating lease liabilities 2,327 (105,494)
Other, net (5,549) (45,754)
Net cash provided by operating activities 1,059,252 1,946,933
Cash flows from investing activities:    
Property additions (1,099,748) (715,542)
Purchases of investments (26,183) (16,979)
Sales and maturities of investments 15,691 16,896
Net cash (used in) investing activities (1,110,240) (715,625)
Cash flows from financing activities:    
Payments on debt 0 (2,975,518)
Payments for repurchase of common stock (1,799,802) (1,093,399)
Cash dividends paid (997,743) (941,531)
Proceeds from issuance of common stock 114,501 146,393
Payments of employee tax withholdings for stock awards (32,451) (24,478)
Net cash (used in) financing activities (2,715,495) (4,888,533)
Effect of exchange rate changes on cash (95,604) (20,749)
Net (decrease) in cash and cash equivalents (2,862,087) (3,677,974)
Cash and cash equivalents at beginning of year 6,226,765 10,469,570
Cash and cash equivalents at end of period $ 3,364,678 $ 6,791,596